| CASE REPORT |
|
| Year : 2008 | Volume
: 53
| Issue : 3 | Page : 140-141 |
|
|
Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream
Vandana Mehta, C Balachandran
Department of Skin and STD, Kasturba Medical College, Manipal, India
Correspondence Address:
Vandana Mehta
Department of Skin and STD, Kasturba Medical College, Manipal - 576 104, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-5154.43204
|
|
|
Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
